InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by SHULMAN JOHN D. Officer active across 1 companies, notably Petros Pharmaceuticals, Inc.. Aggregated, 6 filings have been recorded. Total volume traded: €8.5m. The latest transaction was disclosed on 22 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€442,966145,773 shares@ €3.038710.5% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-22-000036·
Ideal exit: 18 Sept 2022 (T+270)
€442,966145,773 shares@ €3.03875.2% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-22-000036:0·
Ideal exit: 18 Sept 2022 (T+270)
€1m500,000 shares@ €2.656531.4% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-21-144901·
Ideal exit: 26 Aug 2022 (T+270)
€1m500,000 shares@ €2.656515.7% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-21-144901:0·
Ideal exit: 26 Aug 2022 (T+270)
€2m1,661,807 shares@ €1.476758.1% of flow
Common Stock, par value $0.0001 per share
SEC:0001567619-21-018515·
Ideal exit: 15 Jul 2022 (T+270)
€2m1,661,807 shares@ €1.476729.0% of flow
Common Stock, par value $0.0001 per share
SEC:0001567619-21-018515:0·
Ideal exit: 15 Jul 2022 (T+270)
6 of 6 declarations
About SHULMAN JOHN D
John D. Shulman is a director at Petros Pharmaceuticals, Inc.
